Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.47 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.47 |
| ▸ | ITGAL | P20701 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | CNR1 | P21554 | 2/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16273559 | 0.93 | SLC6A5 (0.57) | SLC6A5EPHX2ITGB2ICAM1ITGAL | |
| SCHEMBL16273558 | 0.89 | SLC6A5 (0.69) | SLC6A5EPHX2ITGB2ICAM1ITGAL | |
| SCHEMBL17640671 | 0.85 | SLC6A5 (0.48) | SLC6A5EPHX2ITGB2ICAM1ITGAL | |
| SCHEMBL26624821 | 0.82 | SLC6A5 (0.64) | SLC6A5EPHX2ITGB2ICAM1ITGAL | |
| SCHEMBL3057446 | 0.82 | EPHX2 (0.60) | SLC6A5EPHX2ITGB2ICAM1ITGAL | |
| SCHEMBL29615190 | 0.82 | EPHX2 (0.60) | SLC6A5EPHX2ITGB2ICAM1ITGAL | |
| SCHEMBL27675779 | 0.82 | EPHX2 (0.60) | SLC6A5EPHX2ITGB2ICAM1ITGAL | |
| SCHEMBL17636914 | 0.82 | SLC6A5 (0.59) | SLC6A5EPHX2FAAHCNR1CNR2 | |
| SCHEMBL16070708 | 0.81 | SLC6A5 (0.77) | SLC6A5EPHX2ITGB2ICAM1ITGAL | |
| SCHEMBL29713992 | 0.81 | SLC6A5 (0.77) | SLC6A5EPHX2ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9174931-B2 | Compositions for the treatment of diabetes and pre-diabetes | CELLIX BIO PRIVATE LIMITED (IN) | 2015-11-03 | — | — | US | disclosed |
| US-20150183728-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES AND PRE-DIABETES | CELLIX BIO PRIVATE LIMITED (IN) | 2015-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150183728-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES AND PRE-DIABETES | SLC5A1, GPR119, INSR | SLC6A5 63/4885EPHX2 3867/4885ITGB2 3773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.